Bacterial Vaginosis: New Study Highlights the Importance of Treating Male Partners

A recent study published in *The New England Journal of Medicine* sheds light on bacterial vaginosis (BV), a common condition affecting ⁢nearly a third of women globally, suggesting it can be sexually transmitted.This finding prompts a re-evaluation of‍ current treatment⁣ strategies.

The Need for Further Research on Bacterial vaginosis

While the study’s findings ⁣offer a potential shift in how bacterial vaginosis is ⁢managed, experts emphasize the need for more research. They seek a deeper understanding of how bacterial vaginosis develops, especially considering its potential⁣ to cause infertility, premature births, adn newborn deaths.

Key Findings of the Landmark Study

The study, spearheaded by Lenka‍ A. Vodstrcil, Ph.D., from monash University in ⁤Carlton, Australia, and her team, was‍ published on March 5. The research focused on 164 couples in monogamous relationships where the women had bacterial vaginosis.

The study revealed that treating bacterial vaginosis as a sexually transmitted infection (STI), with both partners receiving simultaneous treatment, resulted in significantly higher cure ‍rates compared to treating only the women.

This successful intervention is relatively cheap and short ⁤-lived and has the potential, for the first time, not only to improve the cure of bacterial vaginosis in women, but also opens new and exciting opportunities for the prevention of bacterial vaginosis.
Catriona S. Bradshaw, Melbourne’s Sexual Health Center at the university of Monash

In the ⁤trial, women in the couple treatment group received recommended antimicrobial agents, while their male partners received oral and topical antimicrobial ⁢treatment‍ (400 mg metronidazole tablets and 2% clindamycin cream applied to the penile skin, both twice daily for seven days).

Conversely, in the control group, women received standard first-line treatment, but their partners received no treatment.⁣ The primary outcome measured was the recurrence of‍ bacterial ⁢vaginosis within 12 weeks.

Historically, over half of women⁣ with ⁤bacterial vaginosis ⁤experience a recurrence within three months following a one-week course of oral antibiotics.

The results showed a significant difference: bacterial⁣ vaginosis recurred in 35% of⁤ women in the couple treatment group compared to 63% in the control group. This led ⁣to the trial being ⁣stopped early because, as the ‍authors wrote, “the treatment of women alone was ⁣inferior to the treatment of women and their male partner.”

Other ⁤factors Influencing Bacterial Vaginosis Development

despite the study’s compelling results, some experts highlight unanswered questions that warrant further examination.

Mykhaylo Usyk, Ph.D., MPH, noted that the study’s sample size was modest and that recurrence ⁢wasn’t eliminated ⁤in all participants. He also questions ⁢the classification of bacterial vaginosis as a ⁣sexually transmitted infection.

I don’t know if I would say that bacterial vaginosis is in itself a sexually transmitted infection… Bacterial vaginosis is also⁤ an indicator, such as fever.It is indeed a symptom of some other⁣ disease.
Mykhaylo Usyk, Ph.D., MPH

Though, ⁤Usyk acknowledges that men can act as a reservoir for the bacteria involved. “There are some underlying germs that men house and,unless we treat them,bacterial vaginosis will return.”

He suggests further research to identify transmissible subtypes of bacterial vaginosis before routinely prescribing antibiotics ⁢to both men and women.

The Role of⁣ lifestyle Factors

Rebecca Brotman, Ph.D.,emphasizes the influence of lifestyle factors on the vaginal microbiome and the development of bacterial vaginosis. These⁣ include smoking and intravaginal practices like douching and lubricant use.

Other contributing factors, such as smoking or intravaginal practices such as vaginal showers and use of lubricants can also alter the vaginal microbiome and contribute vaginal to the development of bacterial vaginosis.
Rebecca ‍Brotman, Ph.D.

Brotman agrees that the trial provides strong evidence supporting the hypothesis ‍that⁣ bacteria associated with bacterial vaginosis can be sexually transmitted. She believes the findings could transform how doctors treat and manage bacterial vaginosis.

She also points out that “even though the essay represents a significant achievement for the treatment of bacterial vaginosis, more research is needed⁤ to validate the findings in other populations. For example, 80 % of the men who⁣ participated in the essay were not circumcised and one third of women used intrauterine devices, ‍both factors can affect the presence of bacteria associated with bacterial vaginosis.”

Brotman highlights existing evidence supporting the sexual transmission of bacterial vaginosis,including its frequent co-occurrence with other‍ STIs,higher prevalence among women with multiple or new sexual partners,and a greater⁢ incidence among women whose male partners have multiple recent partners.

Furthermore, “the use of condom also seems to help reduce the risk of bacterial vaginosis,” she said, “there are⁤ studies that report‍ a lower risk in women who refrain from having ⁣sex or use condoms systematically, while unprotected sex is linked to higher rates of treatment failure.”

“A Great Victory for Women”

Dr. Caroline M.